PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,585,198 | -10.6% | 1,310,048 | +23.5% | 0.21% | -0.5% |
Q2 2023 | $15,187,864 | +284.1% | 1,060,605 | +91.5% | 0.21% | +215.2% |
Q1 2023 | $3,954,339 | -36.1% | 553,829 | +0.4% | 0.07% | -42.6% |
Q4 2022 | $6,191,499 | +1.2% | 551,827 | -0.1% | 0.12% | +7.5% |
Q3 2022 | $6,121,000 | +30.4% | 552,442 | -0.7% | 0.11% | +27.4% |
Q2 2022 | $4,694,000 | -38.0% | 556,105 | -0.0% | 0.08% | +20.0% |
Q1 2022 | $7,571,000 | -29.5% | 556,293 | +1.9% | 0.07% | +14.8% |
Q4 2021 | $10,741,000 | -39.2% | 546,055 | -0.8% | 0.06% | -33.7% |
Q3 2021 | $17,663,000 | -4.5% | 550,240 | +0.7% | 0.09% | +1.1% |
Q2 2021 | $18,500,000 | -39.8% | 546,522 | -33.2% | 0.09% | -45.2% |
Q1 2021 | $30,739,000 | – | 818,385 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 2,484,274 | $27,873,554 | 11.71% |
Frazier Life Sciences Management, L.P. | 8,407,152 | $94,328,245 | 5.86% |
Abingworth LLP | 1,435,106 | $16,101,889 | 5.25% |
Opaleye Management Inc. | 417,500 | $4,684,350 | 1.63% |
683 Capital Management, LLC | 1,350,000 | $15,147,000 | 1.28% |
Newtyn Management, LLC | 484,074 | $5,431,310 | 1.12% |
Penn Mutual Asset Management | 62,802 | $704,638 | 0.79% |
StepStone Group LP | 422,085 | $4,735,794 | 0.62% |
MPM BioImpact LLC | 195,942 | $2,198,469 | 0.57% |
Avidity Partners Management LP | 1,900,000 | $21,318,000 | 0.46% |